Evoke Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Buy |
+3,391
| New | +$376K | 0.01% | 393 |
|
|
2022
Q4 | – | Sell |
-1,197
| Closed | -$74K | – | 681 |
|
|
2022
Q3 | $74K | Buy |
1,197
+31
| +3% | +$1.92K | ﹤0.01% | 461 |
|
|
2022
Q2 | $72K | Sell |
1,166
-317
| -21% | -$19.6K | ﹤0.01% | 453 |
|
|
2022
Q1 | $88K | Buy |
1,483
+238
| +19% | +$14.1K | ﹤0.01% | 449 |
|
|
2021
Q4 | $90K | Buy |
1,245
+2
| +0.2% | +$145 | ﹤0.01% | 462 |
|
|
2021
Q3 | $86K | Sell |
1,243
-7
| -0.6% | -$484 | ﹤0.01% | 447 |
|
|
2021
Q2 | $86K | Sell |
1,250
-7
| -0.6% | -$482 | ﹤0.01% | 460 |
|
|
2021
Q1 | $81K | Sell |
1,257
-54
| -4% | -$3.48K | ﹤0.01% | 401 |
|
|
2020
Q4 | $76K | Buy |
1,311
+681
| +108% | +$39.5K | 0.01% | 323 |
|
|
2020
Q3 | $40K | Sell |
630
-321
| -34% | -$20.4K | ﹤0.01% | 388 |
|
|
2020
Q2 | $73K | Buy |
951
+260
| +38% | +$20K | 0.01% | 311 |
|
|
2020
Q1 | $51.7K | Sell |
691
-2,110
| -75% | -$158K | 0.01% | 341 |
|
|
2019
Q4 | $182K | Buy |
2,801
+97
| +4% | +$6.3K | 0.02% | 234 |
|
|
2019
Q3 | $171K | Buy |
+2,704
| New | +$171K | 0.02% | 280 |
|